Production (Stage)
Senti Biosciences, Inc.
SNTI
$3.11
-$0.10-3.12%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -54.79M | -52.79M | -70.90M | -56.95M | -64.45M |
| Total Depreciation and Amortization | 5.32M | 5.37M | 5.39M | 5.74M | 5.48M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.81M | 1.46M | 18.58M | 402.00K | 4.33M |
| Change in Net Operating Assets | 1.91M | 4.56M | 12.00M | 8.37M | 6.86M |
| Cash from Operations | -43.77M | -41.40M | -34.93M | -42.44M | -47.77M |
| Capital Expenditure | -11.00K | -26.00K | -19.00K | -1.88M | -5.55M |
| Sale of Property, Plant, and Equipment | 60.00K | 60.00K | 165.00K | 105.00K | 105.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 23.00M | 45.00M |
| Cash from Investing | 49.00K | 34.00K | 146.00K | 21.23M | 39.56M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -23.00K | -46.00K | -73.00K |
| Issuance of Common Stock | 49.06M | 49.06M | 589.00K | 579.00K | 887.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4.26M | 4.67M | 2.43M | -- | -- |
| Cash from Financing | 53.32M | 53.73M | 3.00M | 533.00K | 814.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.60M | 12.37M | -31.79M | -20.68M | -7.40M |